CT assessment of liver hemodynamics in patients with hepatocellular carcinoma after argon-helium cryoablation.

[1]  T. Terada,et al.  Vascular supply in adenomatous hyperplasia of the liver and hepatocellular carcinoma: a morphometric study. , 1992, Human pathology.

[2]  A K Dixon,et al.  Functional images of hepatic perfusion obtained with dynamic CT. , 1993, Radiology.

[3]  K. Tanikawa,et al.  Sinusoidal capillarization in small hepatocellular carcinoma , 1994, Pathology international.

[4]  L Pagliaro,et al.  Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. , 2001, Journal of hepatology.

[5]  Argon supper-cryosurgery for patients with middle and late stage liver cancer. , 2003, Hepatobiliary & pancreatic diseases international : HBPD INT.

[6]  Jun Aoki,et al.  Quantitative perfusion map of malignant liver tumors, created from dynamic computed tomography data. , 2004, Academic radiology.

[7]  Lee M Ellis,et al.  Functional CT for quantifying tumor perfusion in antiangiogenic therapy in a rat model. , 2005, Radiology.

[8]  C. Charnsangavej,et al.  Functional CT quantification of tumor perfusion after transhepatic arterial embolization in a rat model. , 2005, Radiology.

[9]  J. Bruix,et al.  Management of hepatocellular carcinoma , 2005, Hepatology.

[10]  S Nahum Goldberg,et al.  Perfusion MDCT enables early detection of therapeutic response to antiangiogenic therapy. , 2008, AJR. American journal of roentgenology.

[11]  Wen He,et al.  Computed tomography perfusion in evaluating the therapeutic effect of transarterial chemoembolization for hepatocellular carcinoma. , 2008, World journal of gastroenterology.

[12]  F. Fazio,et al.  Hepatocellular carcinoma in cirrhotic liver disease: functional computed tomography with perfusion imaging in the assessment of tumor vascularization. , 2008, Academic radiology.

[13]  Yinying Lu,et al.  Prognostic factors and recurrence of hepatitis B-related hepatocellular carcinoma after argon-helium cryoablation: a prospective study , 2009, Clinical & Experimental Metastasis.

[14]  Y. Kodama,et al.  Outcome of MR-guided percutaneous cryoablation for hepatocellular carcinoma. , 2009, Journal of hepato-biliary-pancreatic surgery.

[15]  M. Haider,et al.  Hepatic perfusion imaging: concepts and application. , 2010, Magnetic resonance imaging clinics of North America.

[16]  T. Mikkelsen,et al.  Permeability Estimates in Histopathology-Proved Treatment-Induced Necrosis Using Perfusion CT: Can These Add to Other Perfusion Parameters in Differentiating from Recurrent/Progressive Tumors? , 2011, American Journal of Neuroradiology.

[17]  Jin-ping Li,et al.  Assessment of tumor vascularization with functional computed tomography perfusion imaging in patients with cirrhotic liver disease. , 2011, Hepatobiliary & pancreatic diseases international : HBPD INT.

[18]  Yinying Lu,et al.  Outcomes of ultrasound-guided percutaneous argon-helium cryoablation of hepatocellular carcinoma , 2011, Journal of hepato-biliary-pancreatic sciences.

[19]  Xue-jia Hao,et al.  Early changes of hepatic hemodynamics measured by functional CT perfusion in a rabbit model of liver tumor. , 2012, Hepatobiliary & pancreatic diseases international : HBPD INT.